Key Highlights

  • Moolec Science shares fell 70.22% over one month to $1.61 as of Friday, October 23, 2026.
  • The stock lost 6.69% over one week and 4.75% on the day.
  • A 15-for-1 share consolidation on January 5 cut shares to 726,118 from 10,891,761.
  • Nasdaq compliance on stockholders' equity was regained on May 13, with equity near $11.3 million at March 31.
  • The most recent company announcement is dated May 14, on its GLASO planting campaign.

Moolec Science: Why Did the Stock Fall 70.22% in a Month?

Moolec Science (NASDAQ:MLEC) was priced at $1.61 on Friday, October 23, 2026, a penny stock down 70.22% over one month, 6.69% over one week and 4.75% on the day. No company announcement explains the move: the latest release in its news record is dated May 14. Calculated from the screen, the shares stood near $5.41 a month earlier.

Commercial Services gained 9.85% over the same month, so the stock trailed its group by about 80 percentage points, calculated. The company develops plant-based ingredients through molecular farming, including GLASO safflower oil and animal proteins expressed in crops.

Share Count: How Small Is the Float After the 15-for-1 Consolidation?

On January 5 the company completed a 15-for-1 share consolidation, reducing outstanding shares to 726,118 from 10,891,761. By October 19 the count had risen to about 2.08 million, a gain near 187%, calculated. At $1.83 that day, the market value was about $3.8 million, calculated.

A share base this small can make prices swing sharply on modest volume. A volatility halt and resumption is also on record for the stock.

Nasdaq Equity Requirement: What Did the Panel Process Settle?

Nasdaq issued a staff determination on December 31, 2025 because stockholders' equity was below the $2.5 million minimum. A panel granted an exception through June 29, 2026, and continued trading was approved on January 30 subject to conditions. On May 13 the company said it had regained compliance, with equity of about $11.3 million at March 31.

Equity at that level equals about three times the market value shown on October 19, calculated.

Operations: What Did the Last Announcements Cover?

The most recent releases covered crop work. On May 14 the company completed its 2026 GLASO commercial planting campaign in the United States, identifying 52 genotypes with an average above 60% gamma-linolenic acid. On April 29 it confirmed the first phase of GLASO industrialization, and on April 7 it reported bovine myoglobin expressed in pea seeds.

The 2025 crushing campaign gave about 45% GLA concentration, announced February 13. At the $1.61 screen price and 2.08 million shares, the market value is about $3.35 million, calculated. Commercial Services also rose 14.21% over three months and 4.18% year to date, so the drop was specific to the stock, not to its sector group as a whole.

What to Watch for Moolec Science After the Sell-Off?

The next fixed points are the company's periodic reports and any Nasdaq correspondence. Followers will also look for updates on the 2026 harvest and on the GLASO industrialization work, and whether further share issuance changes the 2.08 million share count, which has nearly tripled since January, calculated.